Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 5/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24285564 | 0.93 | ALK (0.32) | ALKL3MBTL1ALOX5CA1CA2 | |
| SCHEMBL21729917 | 0.91 | ALK (0.34) | ALKL3MBTL1ALOX5CA1CA2 | |
| SCHEMBL18904396 | 0.89 | PDK2 (0.32) | ALKALOX5 | |
| SCHEMBL24236218 | 0.89 | ALK (0.32) | ALK | |
| SCHEMBL17851751 | 0.88 | ALOX5 (0.43) | ALKL3MBTL1ALOX5 | |
| SCHEMBL23919368 | 0.88 | ALK (0.32) | ALK | |
| SCHEMBL13487659 | 0.87 | CASP3 (0.32) | ALKL3MBTL1 | |
| SCHEMBL17851740 | 0.87 | MAPT (0.39) | ALKCA1CA2KDM4EALDH1A1 | |
| SCHEMBL17944585 | 0.87 | MEN1 (0.38) | ALKCA1CA2KDM4EALDH1A1 | |
| SCHEMBL17851754 | 0.87 | HSP90AA1 (0.35) | ALKL3MBTL1ALOX5CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210336154-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE USING THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-28 | — | — | US | disclosed |
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20200212315-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-07-02 | — | — | US | disclosed |
| US-20200181160-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | ALK 1468/4885L3MBTL1 2341/4885ALOX5 4667/4885 |
| US-20200212315-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | OR10J3, ESR1, NFE2L2 | ALK 2005/4885L3MBTL1 713/4885ALOX5 2448/4885 |
| US-20200181160-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | AHR, EMC2, NFE2L2 | ALK 258/4885L3MBTL1 3149/4885ALOX5 2553/4885 |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | ALK 301/4885L3MBTL1 3064/4885ALOX5 2455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.